Gail K. Boudreaux is the CEO of Elevance Health, Inc., a position she has held since November 2017. With a strong background in healthcare, she earned her MBA from Columbia Business School and has extensive experience in leading major healthcare...

Current Market Cap

$91.41B

Number of Employees

104.9K

Total Compensation

2019 - 2023

Trending down by -0.69% last year
Showing total compensation for the last 2019 - 2023

Stock

Up by 0.00% last year

Salary

Up by 0.00% last year

Bonus

Down by -5.00% last year

Other

Up by 21.70% last year

Year

2023

Total Compensation

$6.09M

Salary

$1.60M

Board Justification

The compensation philosophy emphasizes performance-based compensation, aligning executive interests with shareholder interests through a mix of fixed and variable compensation, with a significant portion tied to long-term performance.

Bonus

$3.65M

Board Justification

Based on Company performance, the awards earned as a percentage of their respective target awards for 2023 were 114% for Ms. Boudreaux.

Other

$840.96K

Board Justification

Includes tax equalization payments, corporate aircraft usage, and other perquisites.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock grants were vested in 2023 as the focus is on performance-based compensation and long-term incentives.

Performance Metrics

The performance metrics for determining compensation included Adjusted Net Income, Operating Revenue, and various operational performance measures.

SEC Filing

From March 29, 2024

Gail K. Boudreaux

CEO of Elevance Health

E

Education

MBA from Columbia Business School.

Field of Expertise

Healthcare & Life Sciences - Healthcare

Born

June 1, 1960 - 64 years ago

Is Founder?

No

Current Tenure

7 years 0 months (Nov 2017 - Present)

Previous Experience

CEO of GKB Global Health, LLC and Executive Vice President of United HealthGroup.

View Holdings

Insider Holdings of Gail K. Boudreaux

ELVUNHXEL

$52.76M

-$129.68M (-71.08%)

Last Insider Trade

ELV

$17.06M

ELV at $501.74/share

Jul 22, 2024

Sale